Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers

David, M., Sahay, D., Mege, F. et al. (5 more authors) (2014) Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers. PLoS One, 9 (5). e97771. ISSN 1932-6203

Abstract

Metadata

Authors/Creators:
  • David, M.
  • Sahay, D.
  • Mege, F.
  • Descotes, F.
  • Leblanc, R.
  • Ribeiro, J.
  • Clézardin, P.
  • Peyruchaud, O.
Copyright, Publisher and Additional Information: © 2014 David et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, http://creativecommons.org/licenses/by/4.0/ which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Heparin-binding EGF-like Growth Factor; Humans; Isoxazoles; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Propionates; Prostatic Neoplasms; RNA, Messenger; Receptors, Lysophosphatidic Acid; Signal Transduction; Xenograft Model Antitumor Assays
Dates:
  • Accepted: 23 April 2014
  • Published (online): 14 May 2014
  • Published: 14 May 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Nov 2019 10:37
Last Modified: 25 Nov 2019 14:29
Status: Published
Publisher: Public Library of Science
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pone.0097771
Related URLs:

Export

Statistics